Cargando…

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis

This study aims to evaluate safety issues of house dust mite subcutaneous immunotherapy (SCIT) among allergic rhinitis (AR) children. A retrospective cohort study was done between 2015 and 2020 to investigate the side effects of SCIT among AR children caused by a house dust mite allergy. Among 1098...

Descripción completa

Detalles Bibliográficos
Autores principales:	Endaryanto, Anang, Nugraha, Ricardo Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100360/ https://www.ncbi.nlm.nih.gov/pubmed/35563890 http://dx.doi.org/10.3390/cells11091584

Ejemplares similares

Indonesia-Based Study of the Clinical and Cost-Saving Benefits of Subcutaneous Allergen Immunotherapy for Children with Allergic Rhinitis in Private Practice
por: Endaryanto, Anang, et al.
Publicado: (2021)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
por: Lourenço, Edmir Américo, et al.
Publicado: (2015)

Immunotherapy in the Treatment of Allergic Rhinitis in Children
por: Alamri, Ruba A, et al.
Publicado: (2022)

Pediatric Residency Training amid the COVID-19 Pandemic: Exploring the Impact of Supervision and Clinical Practice Guidelines on Clinical and Financial Outcomes
por: Endaryanto, Anang, et al.
Publicado: (2022)

Trend in the admissions of patients with non-COVID-19 respiratory symptoms during COVID-19 pandemic and its impact on hospital finances in Surabaya, Indonesia
por: Endaryanto, Anang, et al.
Publicado: (2023)

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)

Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice
por: Blume, Steven W., et al.
Publicado: (2015)

Modulating toll-like receptor-mediated inflammatory responses following exposure of whole cell and lipopolysaccharide component from Porphyromonas gingivalis in wistar rat models
por: Nelwan, Sindy Cornelia, et al.
Publicado: (2017)

Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
por: Rattanamanee, Tipyapa, et al.
Publicado: (2022)

Recent Updates of Immunotherapy for Allergic Rhinitis in Children
por: Lin, Chih-Feng, et al.
Publicado: (2023)

Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018)

Efficacy of subcutaneous immunotherapy for patients with asthma and allergic rhinitis in Korea: effect on eosinophilic inflammation
por: Kim, Chang Keun, et al.
Publicado: (2021)

Cluster Subcutaneous Allergen Specific Immunotherapy for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis
por: Feng, Shaoyan, et al.
Publicado: (2014)

Specific immunotherapy (SIT) in the treatment of allergic rhinitis
por: Hagen, Anja, et al.
Publicado: (2010)

Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis
por: Jura-Szołtys, Edyta, et al.
Publicado: (2022)

Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients
por: Sousa, Letícia, et al.
Publicado: (2018)

Effects of Serum Vitamin D and Efficacy of Subcutaneous Immunotherapy in Adult Patients With Allergic Rhinitis
por: Joudi, Maryam, et al.
Publicado: (2019)

Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis
por: Shen, Zhiying, et al.
Publicado: (2019)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Metabolomics Reveals Process of Allergic Rhinitis Patients with Single- and Double-Species Mite Subcutaneous Immunotherapy
por: Zheng, Peiyan, et al.
Publicado: (2021)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
por: Aboshady, Omar Ali, et al.
Publicado: (2014)

The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
por: Incorvaia, Cristoforo, et al.
Publicado: (2011)

Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?
por: TEPETAM, Fatma Merve, et al.
Publicado: (2023)

The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis
por: Huang, Jingyu, et al.
Publicado: (2023)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling
por: Xie, Shaobing, et al.
Publicado: (2022)

Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short‐term treatment effectiveness
por: Liu, Dong, et al.
Publicado: (2023)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis()
por: Chen, Yanqiu, et al.
Publicado: (2016)

Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020)

Brazilian guidelines for allergen immunotherapy in the treatment of allergic rhinitis
por: Aarestrup, Fernando Monteiro, et al.
Publicado: (2023)

Salivary IgG4 Levels Contribute to Assessing the Efficacy of Dermatophagoides pteronyssinus Subcutaneous Immunotherapy in Children with Asthma or Allergic Rhinitis
por: Liu, Jinling, et al.
Publicado: (2023)

Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy
por: Shen, Xiao-Fei, et al.
Publicado: (2023)

Impact of allergic rhinitis and specific subcutaneous immunotherapy on peripheral blood basophils of patients sensitized to Dermatophagoides pteronyssinus
por: Lopes, Ana, et al.
Publicado: (2013)

Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
por: Corren, Jonathan, et al.
Publicado: (2021)

Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pk3t3lm9j1fq9k60ignleuu334